Showing results (131-140 of 167) with videos related to
Sort By:
Pageof 17
Multiple Sclerosis and Related Disorders|April 12, 2016
Relapses in multiple sclerosis: Relationship to disabilityDouglas S Goodin, Anthony T Reder, Robert A Bermel, et al.Human Molecular Genetics|March 17, 2009
Pathway and network-based analysis of genome-wide association studies in multiple sclerosisSergio E Baranzini, Nicholas W Galwey, Joanne Wang, et al.Journal of Magnetic Resonance Imaging : JMRI|January 18, 2019
Multisite reliability and repeatability of an advanced brain MRI protocolDaniel L Schwartz, Ian Tagge, Katherine Powers, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2022
Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated SyndromeManon Rival, Eric Thouvenot, Lucile Du Trieu de Terdonck, et al.The Lancet. Neurology|March 24, 2012
Association between pathological and MRI findings in multiple sclerosisMassimo Filippi, Maria A Rocca, Frederik Barkhof, et al.Multiple Sclerosis and Related Disorders|January 21, 2021
Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 yearsAnn D Bass, Rafael Arroyo, Aaron L Boster, et al.BMC Neurology|November 15, 2013
Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot studyTanuja Chitnis, Charles R Guttmann, Alexander Zaitsev, et al.CNS Drugs|July 26, 2020
Efficacy and Safety of Alemtuzumab Through 9 Years of Follow-up in Patients with Highly Active Disease: Post Hoc Analysis of CARE-MS I and II Patients in the TOPAZ Extension StudyTjalf Ziemssen, Ann D Bass, Regina Berkovich, et al.Genes and Immunity|March 20, 2026
Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patientsSara Benavides, Scott Christley, Kiel M Telesford, et al.Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.Pageof 17